Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H11Br2N5O |
InChIKeyCLFRUTTXUXBVGI-UHFFFAOYSA-N |
CAS Registry2703869-93-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | FR | 08 Jan 2021 |